Oncologist Specialist Intelligence specialises in the high-stakes world of chemotherapy and cancer care. It verifies protocols, flags guideline bias where patients fall outside trial populations, and calculates tumour-specific dosing with precision.
Cross-checks prescribed regimens against established protocols — including eviQ (Cancer Institute NSW), the AU oncology protocol library — verifying cycle timing, drug combinations, pre-medications, and cumulative dose limits.
Identifies when patients fall outside the trial populations that established dosing guidelines, flagging where evidence may not fully apply to the individual case.
Calculates doses based on tumour type, stage, body surface area, and organ function, accounting for the unique pharmacology of each oncology agent.
Monitors lifetime cumulative doses for agents with known toxicity ceilings, such as anthracycline cardiotoxicity and platinum-based nephrotoxicity thresholds.
Recommends appropriate anti-emetic, growth factor, and prophylactic regimens aligned to the emetogenic potential and myelosuppressive risk of each cycle.
Validates cycle intervals, rest periods, and treatment windows to ensure protocol adherence and safe sequencing across multi-agent regimens.
Learn how this Specialist brings protocol-level precision to oncology pharmacy, protecting patients through every cycle of treatment.